Assessing The Coexistence of Adhd, Depression, And Substance Abuse Problems: Treatment for Improving Comorbidities
DOI:
https://doi.org/10.61173/wj7zw564Keywords:
ADHD, Depression, Substance Abuse Disor-der, Comorbidity, Cognitive Therapy, AddictionAbstract
The association between substance addiction and-Attention deficit hyperactivity disorder (ADHD) has been well known for many years. An association between addiction and depression has also been heavily investigated, and in recent years evidence has accumulated to indicate that ADHD increases the risk of depression, but that the causal nature of these associations is still not well understood. Due to certain overlapping psychological characteristics, the most prominent psychiatric comorbidities of ADHD are depression and addiction problems. There is strong evidence for familial and neurobiological commonalities between ADHD and the various other associated psychiatric comorbidities. The overlap in symptom profiles between these mental health issues presents a problem for diagnosis and intervention, both of which suffer from poor validation. This study will assess the implications of a pharmacological method for intervention development and public health messaging, addressing the potential for ADHD to cause or lead to substance use or depression. Early identification and treatment of ADHD and its comorbidities could be key to mitigating the course of later psychiatric morbidity.
References
Psychiatric Association, D. S. (2013). Diagnostic and statistical manual of mental disorders: DSM-5 (Vol. 5, No. 5). Washington, DC: American psychiatric association.
Auclair, V., Harvey, P. O., & Lepage, M. (2016). La thérapie cognitive-comportementale dans le traitement du TDAH chez l’adulte [Cognitive Behavioral Therapy and the Treatment of ADHD in Adults]. Sante mentale au Quebec, 41(1), 291–311. Austerman, J. ADHD and behavioral disorders: Assessment, management, and an update from DSM-5. Clevel. Clin. J. Med. 2015, 82, S3. [Google Scholar] [CrossRef] chen jin
Brown, S. A., & Schuckit, M. A. (1988). Changes in depression among abstinent alcoholics. Journal of studies on alcohol, 49(5), 412-417. Cludius B, Landmann S, Rose N, Heidenreich T, Hottenrott B, Schröder J, et al. Long-term effects of mindfulness-based cognitive therapy in patients with obsessive-compulsive disorder and residual symptoms after cognitive behavioral therapy: twelve-month follow-up of a randomized controlled trial. Psychiatry Res. 2020;291:113–119. doi: 10.1016/ j.psychres.2020.113119. [PubMed] [CrossRef] [Google Scholar]
Cui R. (2015). Editorial: A Systematic Review of Depression. Current neuropharmacology, 13(4), 480. https://doi.org/10.2174 /1570159x1304150831123535
Degenhardt, L., Hall, W., & Lynskey, M. (2003). What is comorbidity and why does it occur?. Comorbid mental disorders and substance use disorders, 10.
Gawin, F. H., & Kleber, H. D. (1986). Abstinence symptomatology and psychiatric diagnosis in cocaine abusers: clinical observations. Archives of general psychiatry, 43(2), 107- 113.
Kessler, R. C. (2004). The epidemiology of dual diagnosis. Biological psychiatry, 56(10), 730-737.
Khantzian, E. J. (1987). The self-medication hypothesis of addictive disorders: focus on heroin and cocaine dependence. The cocaine crisis, 65-74.
Khantzian, E. J. (1997). The self-medication hypothesis of substance use disorders: A reconsideration and recent applications. Harvard review of psychiatry, 4(5), 231-244. Kosheleff, A. R., Mason, O., Jain, R., Koch, J., & Rubin, J. (2023). Functional Impairments Associated With ADHD in Adulthood and the Impact of Pharmacological Treatment. Journal of attention disorders, 27(7), 669–697. https://doi. org/10.1177/1087054723115857 Lalanne, L., Lutz, P. E., Trojak, B., Lang, J. P., Kieffer, B. L., &
Bacon, E. (2016). Medications between psychiatric and Dean&Francis ISSN 2959-6122 addictive disorders. Progress in Neuro-Psychopharmacology and Biological Psychiatry, 65, 215-223.
Markou, A., & Kenny, P. J. (2002). Neuroadaptations to chronic exposure to drugs of abuse: relevance to depressive symptomatology seen across psychiatric diagnostic categories. Neurotoxicity research, 4(4), 297-313.
McHugh, R. K., & Weiss, R. D. (2019). Alcohol Use Disorder and Depressive Disorders. Alcohol research : current reviews, 40(1), arcr.v40.1.01. https://doi.org/10.35946/arcr.v40.1.01
Nunes, E. V., & Levin, F. R. (2004). Treatment of depression in patients with alcohol or other drug dependence: a metaanalysis. Jama, 291(15), 1887-1896.
Pettinati, H. M., O’Brien, C. P., & Dundon, W. D. (2013). Current status of co-occurring mood and substance use disorders: a new therapeutic target. American Journal of Psychiatry, 170(1), 23-30. Powell, V., Agha, S. S., Jones, R. B., Eyre, O., Stephens, A., Weavers, B., Lennon, J., Allardyce, J., Potter, R., Smith, D.,
Thapar, A., & Rice, F. (2021). ADHD in adults with recurrent depression. Journal of affective disorders, 295, 1153–1160. https://doi.org/10.1016/j.jad.2021.09.010
Rappeneau, V., & Bérod, A. (2017). Reconsidering depression as a risk factor for substance use disorder: Insights from rodent models. Neuroscience and biobehavioral reviews, 77, 303–316. https://doi.org/10.1016/j.neubiorev.2017.04.001 Riglin, L., Leppert, B., Dardani, C., Thapar, A. K., Rice, F., O’Donovan, M. C., Davey Smith, G., Stergiakouli, E., Tilling,
K., & Thapar, A. (2021). ADHD and depression: investigating a causal explanation. Psychological medicine, 51(11), 1890–1897. https://doi.org/10.1017/S0033291720000665
Rohner, H., Gaspar, N., Philipsen, A., & Schulze, M. (2023). Prevalence of Attention Deficit Hyperactivity Disorder (ADHD) among Substance Use Disorder (SUD) Populations: Meta- Analysis. International journal of environmental research and public health, 20(2), 1275. https://doi.org/10.3390/ ijerph20021275 Regan T., Tubman J. Attention Deficit Hyperactivity Disorder (ADHD) Subtypes, Co-Occurring Psychiatric Symptoms and Sexual Risk Behaviors among Adolescents Receiving Substance Abuse Treatment. Subst. Use Misuse. 2020;55:119–132. doi: 10.1080/10826084.2019.1657895. [PMC free article] [PubMed] [CrossRef] [Google Scholar] Salvi, V., Ribuoli, E., Servasi, M., Orsolini, L., & Volpe, U. (2021). ADHD and Bipolar Disorder in Adulthood: Clinical and Treatment Implications. Medicina (Kaunas, Lithuania), 57(5), 466. https://doi.org/10.3390/medicina57050466
Schuckit, M. A. (2006). Comorbidity between substance use disorders and psychiatric conditions. Addiction, 101, 76-88. Swendsen, J., Conway, K. P., Degenhardt, L., Glantz, M., Jin,
R., Merikangas, K. R., ... & Kessler. R. C. (2010). Mental disorders as risk factors for substance use, abuse and dependence: results from the 10-year follow-up of the National Comorbidity Survey. Addiction, 105(6), 1117-1128. Zhou H, Polimanti R, Yang BZ, et al. Genetic risk variants associated with comorbid alcohol dependence and major depression. JAMA Psychiatry. 2017;74(12):1234–1241. [PMC free article] [PubMed] [Google Scholar]
Downloads
Published
Issue
Section
License
Copyright (c) 2025 by the authors.
This work is licensed under a Creative Commons Attribution 4.0 International License.
